• Work Experience
• Assistant Professor, 2023-Current
  Department of Molecular Biology and Genetics, Bahçeşehir University, İstanbul/Turkey
• Assistant Professor, 2017-2023
  Department of Medical Biology, Yüksek İhtisas University, Ankara/Turkey
• Quality Control Manager, 2016-2017
  RTA Laboratories, İstanbul/Turkey
• Postdoctoral Fellow, 2015-2016
  Department of Molecular Biology and Genetics, Sabancı University, İstanbul/Turkey
• Research and Teaching Assistant, 2009-2014
  Department of Molecular Biology and Genetics, Bilkent University, Ankara/Turkey
• Education
• PhD Degree in Molecular Biology and Genetics, 2009-2014
  Bilkent University, Ankara/Turkey
• BSc Degree in Biological Sciences, 2005-2009
  Middle East Technical University, Ankara/Turkey
• Visiting PhD Student, 2011-2013
  L’Institut Albert-Bonniot, Université Grenoble Alpes, Grenoble/France

1. Telkoparan-Akillilar, P., & Cevik, D. (2023). Identification of differentially expressed miRNAs and mRNAs associated with the regulation of breast cancer via in silico and in vitro methods. Cytotechnology, 75, 363–379 (2023)
2. Telkoparan-Akillilar, P., Cevik, D., & Yilmaz, A. (2022). Expression patterns of miR-34a, miR-125b, miR-221 and antioxidant gene NRF2 in plasma samples of patients with atherosclerosis. Journal of Biosciences, 47(1), 1–12.
3. Telkoparan-Akillilar, P., & Cevik, D. (2021). The Applications of Next-generation Sequencing (NGS) in Drug Development for Cancer Therapy. Current Analytical Chemistry, 17(8), 1074–1081.
4. Telkoparan-Akillilar, P., & Cevik, D. (2021). Identification of miR-17, miR-21, miR-27a, miR-106b and miR-222 as endoplasmic reticulum stress-related potential biomarkers in circulation of patients with atherosclerosis. Molecular Biology Reports, 48(4), 3503–3513.
5. Telkoparan-Akillilar, P., Panieri, E., Cevik, D., Suzen, S., & Saso, L. (2021). Therapeutic targeting of the NRF2 signaling pathway in cancer. Molecules, 26(5), 1417.
6. Panieri, E., Buha, A., Telkoparan-Akillilar, P., Cevik, D., Kouretas, D., Skaperda, Z., Tsatsakis, A., Wallace, D., & Suzen, S. (2020). Potential Applications of NRF2 Modulators in Cancer Therapy. Antioxidants, 9(193), 3.
7. Cevik, D., Yildiz, G., & Ozturk, M. (2015). Common telomerase reverse transcriptase promoter mutations in hepatocellular carcinomas from different geographical locations. World Journal of Gastroenterology: WJG, 21(1), 311.
8. Ozen, C., Yildiz, G., Dagcan, A. T., Cevik, D., Ors, A., Keles, U., Topel, H., & Ozturk, M. (2013). Genetics and epigenetics of liver cancer. New Biotechnology, 30(4), 381–384.

No positions available